Friday, 26 May 2017

China News

  • Agilent launches new mass spectrometer in China

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singaore: Agilent Technologies has launched Agilent 5977B High Efficiency Source (HES) GC/MSD System, a tandem gas chromatograph and mass spectrometer that delivers lower limits of detectio...Read more

  • India continues to lead China in pharma exports

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: India has maintained its lead over China in terms of pharma exports, according to a statement by the ministry of commerce and industry. The country's pharma rose grew 7.55 perce...Read more

  • Novartis inaugurates its $1 bn research center in China

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Swiss pharma giant Novartis has recently inaugurated its huge $1 billion research center in China. This is the company's third global facility, located in Shanghai and it will fo...Read more

  • Eisai enters license agreement with HUYA Bioscience

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Eisai has entered into an exclusive license agreement with HUYA Bioscience International to develop and market the oral histone deacetylase (HDAC) inhibitor HBI-8000 in Japan, So...Read more

  • Korea's Green cross expands cell therapy business in China

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: South Korean biopharmaceutical company, Green Cross, is expanding its presence in China by building a cell therapy facility to produce and distribute cell therapy products in the...Read more

  • APAC multiple myeloma market to value $2.8 bn by 2021: Report

    China |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, and Australia will rise in value from USD1.7 billion in 2014 to USD2.8 ...Read more

  • Going Strong In Hepatitis Drug Profile

    China |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore:  SINO BIOPHRMACEUTICAL, China Chairman: Mr Ping TseRevenue: $1534.8 mnBusiness: Research, development, manufacturing and marketing of Chinese medicines and chemical medicinesSi...Read more

  • Aussie anesthetic firm gets patent from 7 nations

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australia-based Drawbridge Pharmaceuticals has been granted patent for its anesthetic formulation Phaxan in the UK, Australia, New Zealand, Hong Kong, Singapore and South Africa....Read more

  • Foreign firms in China worried after GSK probe

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: As per British risk consultancy Control Risks, foreign firms operating in China are worried that companies in China lack adequate protection against corruption investigations. M...Read more

  • Investigators probed in GSK China scandal formally arrested

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: After almost six weeks of detention and probing, the husband-wife duo of foreign investigators, Mr Peter Humphrey and Ms Yu Yingzeng were formally arrested by the Shanghai police...Read more

  • Innovation is the key to drive pharma industry in China

    China |  News | By Amrita Tejasvi | 0 Comment

    In 13th five-year plan, China has highlighted innovation as the key to drive healthcare industry. What are plans of pharmaceutical companies to drive innovation that complements the nation'...Read more

  • Singapore, China universities strengthen ties

    China |  News | By BioSpectrum Bureau | 0 Comment

    To mark the 25th anniversary of diplomatic relations between Singapore and the People's Republic of China (PRC), three universities from each country signed three Memoranda of Understanding...Read more

  • Singapore's Fortis Surgical Hospital is now Concord Medical Services

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Concord Medical Services, China based hospital management solution provider, has received Singapore's approval to change the name of the Fortis Surgical Hospital, which was acqui...Read more

  • Eisai buys Chinese Generics Company Liaoning TianYi

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Eisai announced that regarding the acquisition of Chinese generic pharmaceutical company Liaoning TianYi Biological Pharmaceutical previously announced on November 27, 2015, the ...Read more

  • CMC, RuiYi develop monoclonal antibodies cell line

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: US-based contract biopharmaceutical manufacturing CMC Biologics has collaborated with China-focused RuiYi to develop a cell line for RYI-008, a novel anti-IL-6 monoclonal antibod...Read more

  • Hutchinson begins human clinical trial of cancer drug

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Hutchison MediPharma (HMP) has initiated the first-in-human phase I clinical trial of Theliatinib (HMPL-309). This is the fourth oncology compound from the internal discovery pr...Read more

  • Now allegations against infant formulation giant in China

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Accusations of bribing medical staff to boost sales of infant formulas at hospitals in Northern China were hurled against Dumex, a unit of French food group Danone's milk powder ...Read more

  • China ramps up efforts to curb Ebola

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The Chinese mobile laboratory stationed at the Sierra Leone-China Friendship Hospital at Jui, is playing an instrumental role in facilitating Ebola laboratory tests in the devast...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls